These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 12503925)

  • 1. Adverse drug events associated with hospital admission.
    Peyriere H; Cassan S; Floutard E; Riviere S; Blayac JP; Hillaire-Buys D; Le Quellec A; Hansel S
    Ann Pharmacother; 2003 Jan; 37(1):5-11. PubMed ID: 12503925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for hospital admissions associated with adverse drug events.
    Kongkaew C; Hann M; Mandal J; Williams SD; Metcalfe D; Noyce PR; Ashcroft DM
    Pharmacotherapy; 2013 Aug; 33(8):827-37. PubMed ID: 23686895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use.
    Page RL; Ruscin JM
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):297-305. PubMed ID: 17296535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients.
    Hamilton H; Gallagher P; Ryan C; Byrne S; O'Mahony D
    Arch Intern Med; 2011 Jun; 171(11):1013-9. PubMed ID: 21670370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computerized surveillance of adverse drug events in hospital patients.
    Classen DC; Pestotnik SL; Evans RS; Burke JP
    JAMA; 1991 Nov; 266(20):2847-51. PubMed ID: 1942452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing adverse drug events in hospitalized patients.
    Evans RS; Pestotnik SL; Classen DC; Horn SD; Bass SB; Burke JP
    Ann Pharmacother; 1994 Apr; 28(4):523-7. PubMed ID: 8038479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug events in hospitalized patients treated with cardiovascular drugs and anticoagulants.
    Zaidenstein R; Eyal S; Efrati S; Akivison L; Michowitz MK; Nagornov V; Golik A
    Pharmacoepidemiol Drug Saf; 2002; 11(3):235-8. PubMed ID: 12051123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detecting adverse drug events during the hospital stay].
    Berga Culleré C; Gorgas Torner MQ; Altimiras Ruiz J; Tuset Creus M; Besalduch Martín M; Capdevila Sunyer M; Torres Gubert M; Casajoana Cortinas MT; Baró Sabaté E; Fernández Solà JR; Moron i Besolí A; Odena Estradé E; Serrais Benavente J; Vitales Farrero MT; Codina Jané C
    Farm Hosp; 2009; 33(6):312-23. PubMed ID: 20038390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for the development of adverse drug events in hospitalized patients.
    van den Bemt PM; Egberts AC; Lenderink AW; Verzijl JM; Simons KA; van der Pol WS; Leufkens HG
    Pharm World Sci; 2000 Apr; 22(2):62-6. PubMed ID: 10849925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical approach to determining costs and frequency of adverse drug events in a health care network.
    Senst BL; Achusim LE; Genest RP; Cosentino LA; Ford CC; Little JA; Raybon SJ; Bates DW
    Am J Health Syst Pharm; 2001 Jun; 58(12):1126-32. PubMed ID: 11449856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse drug events in patients with advanced chronic conditions who have a prognosis of limited life expectancy at hospital admission.
    Sevilla-Sanchez D; Molist-Brunet N; Amblàs-Novellas J; Roura-Poch P; Espaulella-Panicot J; Codina-Jané C
    Eur J Clin Pharmacol; 2017 Jan; 73(1):79-89. PubMed ID: 27704168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using a hospital information system to assess the effects of adverse drug events.
    Evans RS; Classen DC; Stevens LE; Pestotnik SL; Gardner RM; Lloyd JF; Burke JP
    Proc Annu Symp Comput Appl Med Care; 1993; ():161-5. PubMed ID: 8130454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital admissions caused by adverse drug events: an Australian prospective study.
    Phillips AL; Nigro O; Macolino KA; Scarborough KC; Doecke CJ; Angley MT; Shakib S
    Aust Health Rev; 2014 Feb; 38(1):51-7. PubMed ID: 24351707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality.
    Classen DC; Pestotnik SL; Evans RS; Lloyd JF; Burke JP
    JAMA; 1997 Jan 22-29; 277(4):301-6. PubMed ID: 9002492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of adverse drug events in public and private hospitals in Riyadh, Saudi Arabia: the (ADESA) prospective cohort study.
    Aljadhey H; Mahmoud MA; Ahmed Y; Sultana R; Zouein S; Alshanawani S; Mayet A; Alshaikh MK; Kalagi N; Al Tawil E; El Kinge AR; Arwadi A; Alyahya M; Murray MD; Bates D
    BMJ Open; 2016 Jul; 6(7):e010831. PubMed ID: 27406640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulation-associated adverse drug events.
    Piazza G; Nguyen TN; Cios D; Labreche M; Hohlfelder B; Fanikos J; Fiumara K; Goldhaber SZ
    Am J Med; 2011 Dec; 124(12):1136-42. PubMed ID: 22114827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventable and non-preventable adverse drug events in hospitalized patients: a prospective chart review in the Netherlands.
    Dequito AB; Mol PG; van Doormaal JE; Zaal RJ; van den Bemt PM; Haaijer-Ruskamp FM; Kosterink JG
    Drug Saf; 2011 Nov; 34(11):1089-100. PubMed ID: 21981436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug events in surgical patients: an observational multicentre study.
    de Boer M; Boeker EB; Ramrattan MA; Kiewiet JJ; Dijkgraaf MG; Boermeester MA; Lie-A-Huen L
    Int J Clin Pharm; 2013 Oct; 35(5):744-52. PubMed ID: 23722455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug events in hospitalized patients with chronic kidney disease.
    Hassan Y; Al-Ramahi RJ; Aziz NA; Ghazali R
    Int J Clin Pharmacol Ther; 2010 Sep; 48(9):571-6. PubMed ID: 20860910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventable adverse drug events and their causes and contributing factors: the analysis of register data.
    Jylhä V; Saranto K; Bates DW
    Int J Qual Health Care; 2011 Apr; 23(2):187-97. PubMed ID: 21242162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.